Results 161 to 170 of about 355,043 (324)

Unrepaired most severe form of hypoplastic left heart syndrome in adulthood: a case report of late diagnosis and long-term follow-up. [PDF]

Eur Heart J Case Rep
Alanís-Naranjo JM, Angulo-Cruzado ST, García-Cruz E, Patrón-Chi SA, de la Mora-Cervantes R.   +4 more
europepmc   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Stanisław Leszczyński, roi de Pologne et duc de Lorraine

Perspective, 2007
Bogna Kietlińska
doaj   +1 more source

Silent Inferolateral Postinfarction Left Ventricular Outpouching With Thrombus: Cardiac Magnetic Resonance Assessment. [PDF]

JACC Case Rep
Alanís-Naranjo JM, Patrón-Chi SA, Sánchez-Tapia P, Lozano-Cruz OA, Damas-de Los Santos F, Cruz-Marmolejo MÁ, Campuzano-González D, Meléndez-Ramírez G, Meave-González A.   +8 more
europepmc   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Mandatory Responsible Beverage Service Training in California Associated With Higher Refusals of Service to Apparently Intoxicated Patrons. [PDF]

J Stud Alcohol Drugs
Saltz R, Paschall MJ, O'Hara S, Buller DB, Woodall WG, Martinez L.   +5 more
europepmc   +1 more source

A loving triumph over the ravages of war [PDF]

, 2017
Patron, Marie Claire
core  

Other Tobacco Product Use Among Sexual Minority Young Adult Bar Patrons

, 2017
Amanda Fallin‐Bennett, Nadra E. Lisha, Pamela M. Ling   +2 more
openalex   +2 more sources

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

Molecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, Raffaella Picco, Monica Colitti, Francesca D'Este, Mariachiara Gani, Wayne W. Hancock, Giovanni Terrosu, Cristina Degrassi, Francesca Agostini, Claudio Brancolini, Luigi E. Xodo, Eros Di Giorgio   +13 more
wiley   +1 more source

Patrons

Zygon: Journal of Religion and Science, 1997
openaire   +2 more sources